Board Changes
posted in: Uncategorized 0
TORONTO, ONTARIO – May 28, 2025 – OB Pharmaceuticals, Inc. announces the retirement of two founding Board members, Andrew Clarke … Read More
OB Pharmaceuticals announces its poster presentation at the annual meeting of the American Epilepsy Society
posted in: American Epilepsy Society, Events, Uncategorized 0
TORONTO, ONTARIO – December 4, 2020 – OB Pharmaceuticals, Inc., announced today the company will present its poster on its … Read More
OB Pharmaceuticals announces the appointment of Dr. Michael Rogawski
posted in: Michael Rogawski 0
LONDON, ONTARIO June 12, 2020 — OB Pharmaceuticals announces the appointment of Dr. Michael Rogawski to Chief Scientific Advisor and … Read More
New Patents Awarded
LONDON, ONTARIO June 12, 2020 — OB Pharmaceuticals has been granted patent US 10,618,870 from the U.S. Patent and Trademark … Read More
Biotechnology Innovation Organization’s International Convention
posted in: Conventiion, Larry Mahan 0
LONDON, ONTARIO June 12, 2020 — Dr. Larry Mahan, CEO of OB Pharmaceuticals, attended the Biotechnology Innovation Organization’s International Convention … Read More
OB Pharmaceuticals announces the addition of two new members.
posted in: Uncategorized 0
LONDON, ONTARIO February 25, 2020 — OB Pharmaceuticals announces the addition of two new members to its Scientific and Clinical … Read More
Dr. Larry Mahan attended the Park City Epilepsy Conference
posted in: Larry Mahan 0
LONDON, ONTARIO October 10, 2019 — Dr. Larry Mahan attended the Park City Epilepsy Conference held in Park City, UT … Read More
In Memoriam
posted in: Michael Poulter 0
LONDON, ONTARIO August 20, 2019 — It is with great sadness that OB Pharmaceutical announces the sudden death of its … Read More
OB Pharmaceuticals CSO, Dr. Michael Poulter in the News
posted in: Michael Poulter, Uncategorized 0
LONDON, ONTARIO May 16, 2019 — OB Pharmaceuticals CSO, Dr. Michael Poulter in the News. Dr. Michael Poulter, CSO was … Read More
Chairman and CEO John Poulter announced the appointment of Dr. Larry Mahan as the new CEO of OB Pharmaceuticals (OB).
posted in: John Poulter, Larry Mahan 0
LONDON, ONTARIO April 2, 2018 — Chairman and CEO John Poulter announced the appointment of Dr. Larry Mahan as the … Read More